The Valley Desk

Clinical trial reportJCI insightPublished

Icotrokinra induces early and sustained pharmacodynamic responses in phase IIb study of patients with moderate-to-severe psoriasis

27 of 34 authors shown in byline order.

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
JCI insight
Published
Subject terms
Skin; Humans; Psoriasis; Interleukin-17; Treatment Outcome; Severity of Illness Index; Double-Blind Method; Dose-Response Relationship, Drug; Adult; Middle Aged; Female; Male
PubMed ID
41424381
PubMed Central ID
PMC12890502
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal